"Designing Growth Strategies is in our DNA"
The U.S. substance use disorder treatment market size was valued at USD 35.14 billion in 2021 and is projected to grow from USD 37.24 billion in 2022 to USD 60.18 billion by 2029, exhibiting a CAGR of 7.1% during the forecast period. Based on our analysis, the market exhibited a decline of 20% in 2020 as compared to 2019. The global COVID-19 pandemic has been unprecedented and staggering, with substance use disorder treatment experiencing lower-than-anticipated demand across the U.S. compared to pre-pandemic levels.
Substance abuse is a condition in which uncontrolled use of substances, such as tobacco, illicit drug, and alcohol, may further lead to addiction. In this, an individual further gets impaired from his ability to function in day-to-day life. This addiction requires individualized treatments and modalities that can address the symptoms by addressing the primary cause of the disease.
The rising number of patients seeking assistance for substance use disorder treatment, with the increasing number of service providers providing residential treatment facilities, is fueling the market growth during the forecast period. Also, the rising number of physical therapy rehabilitation centers in the country and the increasing number of people enrolling for Medicare beneficiary’s plans for insurance coverage is contributing to the U.S. substance use disorder treatment market growth during the forecast period.
Decline in the Number of Patient Visits to Drug Rehabilitation Facilities Led to Downfall in Revenues
The emergence of COVID-19 has impeded the demand for substance abuse treatments due to decreased patient visits to drug rehabilitation centers. Key players in the market recorded a significant decline in revenues due to the COVID-19 pandemic. The restrictions on movements, the declining number of patient visits to rehabilitation centers and residential settings, and other major parameters impacted the revenues of these service providers in the U.S. substance use disorder treatment market.
The market players witnessed a significant decline in revenue generated during 2020. For instance, Hazelden Betty Ford Foundation generated a revenue of USD 186.3 million in 2020 and witnessed a decline of 6.1% as compared to USD 198.5 million in 2019, owing to the COVID-19 pandemic.
However, during Q3-Q4 2020, the number of patient visits to the hospital started increasing as travel restrictions imposed by the government were relaxed. In 2021, the number of patient visits began returning to normal, owing to higher COVID-19 vaccination coverage among the general population, dismissal of restrictions for travel, and others. This led to increased number of visits by patients seeking substance abuse treatment to rehabilitation centers and other treatment facilities, which led to growth in the revenues of service providers. For instance, Hazelden Betty Ford Foundation generated a revenue of USD 204.7 million in 2021 and witnessed a growth of 9.9% as compared to USD 186.3 million in 2020. Therefore, the resumption of services positively impacted the demand for substance use disorder treatment in 2021.
Request a Free sample to learn more about this report.
Introduction of Virtual Behavioral Health Programs by Rehabilitation Centers is Anticipating Market Growth
The substance use disorder treatment market growth is subjected to the continuous innovations and development of technologically advanced treatments by market players, contributing to the expansion of the market. Digital health interventions are navigating this complex landscape of society. The most common modality adopted in this technology is telehealth and computer-assisted tools. Thus, the easy accessibility of this technology is likely to contribute to the growth of these programs in the market.
Such innovative technology is likely to accelerate the demand for these products at a rapid pace. Also, an increase in collaboration among players to extend the market reach of these programs is likely to contribute to the market's growth.
Increasing Number of Patients Seeking Substance Abuse Treatment is Propelling the Market Growth
The rising prevalence of neurological and psychological disorders, such as depression, schizophrenia, sudden mood swings, irritability, and personality disorders, among the general population in the U.S. is due to the rising number of people consuming alcohol and other illicit drugs. For instance, in September 2021, the Freedom Center Outpatient Recovery Center published an article stating that schizophrenia affects around 1.5 million people in the U.S. annually.
Also, the irrational and impulsive use of substances by the teenage population of the country has led to the development of dangerous addictive habits among youth of the country at an early stage.
This number of people falling victim to substance abuse at a young age contributes to an increase in admissions to substance abuse treatment facilities. For instance, according to the statistics published by the Substance Abuse and Mental Health Services Administration (SAMHSA) in 2020, in the U.S., there were 1,090,357 clients for the treatment of substance abuse, among which 39,271 clients were under 18 years of age.
Rising Penetration of Insurance Coverage for the Treatment of Substance Abuse is Driving the Market Growth
Addiction is a chronic, relapsing, and remitting disorder that profoundly burdens healthcare services. The cost of the rehabilitation program depends on the type of treatment center and admission of an individual to the inpatient or outpatient program. The standard treatment for any addiction ranges between USD 2,000 to USD 25,000 per month, and sometimes with all the luxury, it can cost up to USD 80,000 per month. This inflated cost of the treatment has led the general population to buy insurance coverage for substance abuse treatment.
This rising use of illicit drugs has allowed many entrepreneurs to enter the substance use disorder treatment market. It has increased the number of physical therapy rehabilitation centers in the country.
This led to an increase in the launch of new insurance programs providing coverage for the treatment of substance use disorder, which is likely to boost the growth of this market during the forecast period.
Delay in Diagnosis for a Substance Abuse is Restraining the Market Growth
Patients' reluctance toward substance abuse treatment is the most common reason for delay in the diagnosis of the disease in an individual. The major factors for this reluctance are either the patient is unaware of the treatment or they don’t consider themselves to have any substance use complications. Another factor for not pursuing substance abuse treatment is the lack of interest of any individual in prohibiting the abuse of any substance.
Another reason for patients not undergoing substance abuse treatment is the lack of awareness about the treatment facility, not finding the type of treatment they want, or being concerned that their neighbors and community will have a negative opinion of them.
Therefore, the patient's reluctance to make an effort to get treatment for substance abuse treatment disorder is contributing to a decrease in the number of visits to rehabilitation centers and restraining the market growth.
To know how our report can help streamline your business, Speak to Analyst
Level 2 to Lead Due to Number of Patients Undergoing Outpatient Services or Partial Hospitalization Services
Based on level of care, the U.S. substance use disorder treatment market is segmented into early intervention, level 1/outpatient services, Level 2, Level 3, and Level 4/medically managed intensive inpatient services.
Every individual seeking substance abuse treatment has different needs, sometimes, the patient may require intensive inpatient care, or an individual can get success for treatment in an outpatient setting. In the U.S., substance use disorder treatment centers must adhere to the standards of care put forth by the American Society of Addiction Medicine (ASAM). This professional medical society has featured a “continuum of care,” a flexible treatment system in which people can enter at a level most suitable for them and step up or move down, if necessary.
Level 2 segment is expected to account for the highest market share of the segment during the forecast period. The program's ability, which enables patients to continue with their normal, day-to-day activities and assistance of the program in relapse management, is anticipating the segment’s growth.
The level 1/outpatient service segment is expected to register a comparatively higher CAGR during the forecast period. The rising focus of substance use treatment providers on expanding their outpatient services contributes to the segment's growth. For instance, in November 2021, a behavioral health business published news that stated that Regard Recovery LLC, a mental health and addiction treatment service provider, acquired JourneyPure LLC. This acquisition aims to add 15 new outpatient centers in 2022 and expand its operational facilities.
The early intervention program accounted for a significant market share during the forecast period. The emphasis of substance use disorder treatment providers on introducing early intervention programs propels the segment's growth. For instance, in June 2022, Stepping Stone, a non-profit organization that operates a 31-bed residential treatment facility, launched the StepIn program, an early intervention pilot program for the prevention and education of individuals who use recreational and prescription drugs.
Rising Number of Illicit Drug Users to Accelerate Opportunities for the Drug Abuse Treatment Providers
Based on application, the U.S. substance use disorder treatment market is segmented into alcohol addiction treatment, drug abuse treatment, nicotine addiction treatment, and opioid addiction treatment.
The market is dominated by drug abuse treatment, which is expected to account for the largest share during the forecast period. Major factors contributing to the higher share of the segment include an increase in the number of illicit drug users in the country. For example, according to the statistics published by the National Center for Drug Abuse Statistics in America, as of 2020, there are 37.3 million users of illegal drugs aged above 12 years, and every year, 3.1 million and 1.1 million teenagers are introduced to marijuana and hallucinogens.
The alcohol addiction treatment segment is expected to grow at the highest CAGR during the forecast period. The increasing number of people involved in alcohol abuse each year contributes to the segment's growth. For instance, according to the statistics published by National Center for Drug Abuse Statistics, 4.9 million people are introduced to alcohol abuse each year. Also, the use of alcohol among adolescents aged 12 to 17 increased by 4.4% from 2018 to 2019.
The opioid addiction treatment segment is anticipated to witness substantial growth during the forecast period. The rising number of illegal or misused prescription opioid exposure cases and the expansion of insurance coverage from regulatory authorities are contributing to the segment's growth. For instance, according to the statistics published by National Center for Drug Abuse Statistics, 284,000 illegal or misused prescription opioid cases are reported each year, among which 44.0% of cases are of children under five years. Also, effective from January 2020, the Centers for Medicare & Medicaid Services (CMS) have finalized the expansion of Medicare insurance coverage, including the opioid treatment programs that deliver Medication-Assisted Treatment (MAT).
Thus, the growing number of alcohol and illicit drug abusers and the expanded insurance coverage provided by the regulatory authorities will likely boost the application segment during the forecast period.
Increased Number of Adult Patients Visits in Treatment Facility is to Propel Segment’s Growth
The market is segmented into adult and adolescent in terms of age group.
The adult segment dominated the U.S. market in 2021. The increased abuse of substances among the adult population has increased inpatient admissions to hospitals and substance abuse treatment centers. For instance, according to statistics published by the National Survey of Substance Abuse Treatment Services in 2020, around 30,589 patients in the U.S. visited federal government facilities for the treatment of substance abuse, among which only 127 patients were under the age of 18, which demonstrates that the visit of the adult population for the treatment of substance abuse in the U.S. is comparatively greater.
The adolescent segment is expected to grow at the highest CAGR during the forecast period. The rise in incidents of children getting involved in cases of alcohol consumption or use of any illicit drug at an early stage is propelling the segment's growth. For instance, according to the data published by National Center for Drug Abuse Statistics, 2 million children aged below 18 years have reported drug use across the nation, and approximately 591,000 teenagers of the same age group have used an illicit drug once in their life span.
Thus, the rising number of individuals getting involved in the complexities of illicit drug or alcohol consumption and the rise in the number of patients visiting the substance use treatment facility is contributing to the growth of the segment.
Dedicated Teams for the Treatment of Substance Abuse in Hospital Settings is Anticipating the Growth of the Segment
The U.S. substance use disorder treatment market is segmented into rehabilitation centers, hospitals and specialty clinics, sober living homes, and others in terms of service provider.
The increasing number of patient visits to hospital emergency departments in the U.S. for the treatment of patients involved in alcohol and other substance use disorders demonstrated an urgency for hospitals to develop a system for providing addiction treatment in their emergency and inpatient care. For instance, according to an article published by the Regents of the University of California in September 2021, the visits made by adults with alcohol and substance use disorders to the hospital’s emergency department increased by 30.0%, and the hospitalizations rate for substance use disorder increased by 57.0%.
The hospitals and specialty clinics segment accounted for the highest market share during the forecast period. Introducing substance abuse treatment services in hospital settings has contributed to the segment’s growth. For instance, according to an article published by National Public Radio (NPR) in September 2022, Salem Hospital introduced an addiction consult service at their hospital in the U.S. The service includes the consultation of substance use disorder patients and navigating them with further treatment options.
The rehabilitation centers segment is estimated to grow at the highest CAGR during the forecast period. The rising number of patient admissions to rehabilitation centers for substance use treatment contributes to the segment’s growth. For instance, in August 2022, Mayflower Recovery published an article stating that more than 4.0 million people in the U.S. enter a drug rehabilitation program each year.
The sober living homes segment is anticipated to grow significantly during the forecast period. The rising investment in introducing recovery residencies in the country's different states is contributing to the segment’s growth. For instance, according to an article published by RTI international in January 2022, there were 10,558 recovery residencies between January 2020 and 2021. These residential facilities operate in all 50 states of the U.S. and demonstrate that 30% of the U.S. has at least one residential treatment facility.
Launch of New Clinical Programs and Collaborations among Companies Adopted by the Market Players
The U.S. substance use disorder treatment market share is characterized by players such as Hazelden Betty Ford Foundation, Pyramid Healthcare Inc., and Acadia Healthcare. The players focus on introducing new substance-use treatment programs and emphasize strategic partnerships and collaborations to strengthen their position in this market.
Moreover, the market is further characterized by a large proportion of residential and outpatient facility providers focused on providing behavioral treatment facilities and different reprocessing therapies.
An Infographic Representation of U.S. Substance Use Disorder Treatment Market
To get information on various segments, share your queries with us
The U.S. substance use disorder treatment market research report provides a detailed market analysis. It focuses on key aspects such as the launch of new programs, patient admissions for substance abuse treatment, and the prevalence of substance abuse. Besides this, the report offers insights into the market trends and highlights key industry developments such as mergers, partnerships, and acquisitions and the impact of COVID-19 on the market. In addition to the above mentioned factors, the report encompasses several factors that have contributed to the market's growth in recent years.
Value (USD billion)
By Level Of Care, Application, Age Group, Service Provider, and Geography
By Level of Care
By Age Group
By Service Provider
Fortune Business Insights says that the global market size was USD 35.14 billion in 2021 and is projected to reach USD 60.18 billion by 2029.
In 2021, the market value stood at USD 35.14 billion.
Registering a CAGR of 7.1%, the market will exhibit steady growth in the forecast period (2022-2029).
The level 2 segment is expected to lead this market during the forecast period.
Increasing number of patients seeking substance abuse treatment is one of the key factors driving the market.
“Kudos to your team. Thank you very much for your support and agility to answer our questions.”- Europe-based provider of solutions to automate data centre operations.
“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”- India-based manufacturer of industrial and specialty intermediates with a strong global presence.
“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”- One of the largest cosmetics company in the world.
“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”- U.S. based startup operating in the cultivated meat market.
“We received the below report on the U.S. market from you. We were very satisfied with the report.”- UGlobal hearing aids manufacturer.
“I just finished my first pass-through of the report. Great work! Thank you!”- U.S. based solar racking solutions provider.
“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”- World’s leading advisory firm.
“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”- Germany based machine construction company.
“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”- Japanese manufacturing company of stationery products.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry